Ce blood test was developed by British researchers. More accurate than current tests, this blood test is called « Prostate Screening EpiSwitch » ou PSE. Its purpose is to spot in the blood chromosomal conformations features of this type of cancer. The study carried out compared two groups of patients, those undergoing a standard test, PSA, and those undergoing the new PSE blood test. After analysis, the PSE tests, combining the two techniques, allowed find more prostate cancerwith a accuracy close to 94% (source 1).
Replace an invasive biopsy
Currently, to diagnose prostate cancer, the standard PSA test, antigen blood test, is used but not precise enough. To confirm or not the risk of cancer, a biopsy is neededwhich turns out to be often useless because most have only mild disease and not cancer (source 2).
“Only regarding a quarter of people who undergo a prostate biopsy because of high PSA levels have prostate cancer,” said Professor Dmitry Pshezhetskiy, lead author of the study.
The new PSE test might, in addition to a efficiency gainavoid many invasive biopsies and farea to save time for the prevention and the screening why cancer
